These mechanistic details will allow us to specifically target the lipid-binding function of HspA1A in order to inhibit the lipid-driven translocation of HspA1A to the cell surface of tumor cells, making them sensitive to radiation therapy. This evidence concerns the gene HSPA1A and neoplasm.